U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C23H19N3O2
Molecular Weight 369.4159
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of TIVANTINIB, (+)-

SMILES

O=C1NC(=O)[C@@H]([C@H]1C2=CNC3=C2C=CC=C3)C4=CN5CCCC6=CC=CC4=C56

InChI

InChIKey=UCEQXRCJXIVODC-WOJBJXKFSA-N
InChI=1S/C23H19N3O2/c27-22-19(16-11-24-18-9-2-1-7-14(16)18)20(23(28)25-22)17-12-26-10-4-6-13-5-3-8-15(17)21(13)26/h1-3,5,7-9,11-12,19-20,24H,4,6,10H2,(H,25,27,28)/t19-,20-/m1/s1

HIDE SMILES / InChI

Approval Year

Name Type Language
TIVANTINIB, (+)-
Common Name English
(3S,4S)-3-(5,6-DIHYDRO-4H-PYRROLO(3,2,1-IJ)QUINOLIN-1-YL)-4-(1H-INDOL-3-YL)-2,5-PYRROLIDINEDIONE
Systematic Name English
2,5-PYRROLIDINEDIONE, 3-(5,6-DIHYDRO-4H-PYRROLO(3,2,1-IJ)QUINOLIN-1-YL)-4-(1H-INDOL-3-YL)-, (3S,4S)-
Systematic Name English
Code System Code Type Description
FDA UNII
E9UU0ESM69
Created by admin on Sat Dec 16 13:34:25 UTC 2023 , Edited by admin on Sat Dec 16 13:34:25 UTC 2023
PRIMARY
EU-Orphan Drug
EU/3/09/678
Created by admin on Sat Dec 16 13:34:25 UTC 2023 , Edited by admin on Sat Dec 16 13:34:25 UTC 2023
PRIMARY Please note that this product was withdrawn from the Community Register of designated Orphan Medicinal Products in January 2012 on request of the Sponsor.
CAS
905854-03-7
Created by admin on Sat Dec 16 13:34:25 UTC 2023 , Edited by admin on Sat Dec 16 13:34:25 UTC 2023
PRIMARY
PUBCHEM
11696354
Created by admin on Sat Dec 16 13:34:25 UTC 2023 , Edited by admin on Sat Dec 16 13:34:25 UTC 2023
PRIMARY